Skip to main content
SpringerLink
Log in

Histological features of prognostic significance in CML — an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

To evaluate the prognostic significance of clinical as well as histological disease features at the time of diagnosis, an immunohistochemical and morphometric study was performed on bone marrow trephine biopsies in 130 patients with Ph1+-CML. For identification of all cell elements of the megakaryocytopoiesis we used the monoclonal antibody CD61 (Y2/51) and for the macrophages, the recently characterized antibody PG-M1. Density of argyrophilic fibers was determined per fat cell-free marrow area. Based on a multivariate analysis-derived risk model, the reproducibility of the prognostic score described by Sokal and co-workers was tested, particularly with regard to histological variables. Additionally, we calculated the disease-specific loss in life expectancy. Our prognostic model (Cox model) consisted of the variables: age, spleen size, peripheral erythro-normoblasts, pseudo-Gaucher cells, and fiber density. To assess the validity of this new CML score, a receiver-operating curve (ROC) of sensitivity and specificity was constructed. The improved prognostic efficiency of this newly developed risk model in predicting death within 3 years after diagnosis of CML was demonstrated in comparison with generally accepted staging systems. Immunohistochemistry revealed that not the total number of macrophages, but only the subfraction of pseudo-Gaucher cells exerted a significant impact on survival. Furthermore, it was feasible to calculate the number of atypical micromegakaryocytes and pro-and megakaryoblasts. This abnormal and immature cell population showed a significant correlation with fiber density and prognosis. Finally, the practical value of the Hannover classification was tested. This histological classification enabled a discrimination between two groups with different survival patterns, i.e., granulocyte and/or megakaryocyte-rich subtypes versus subtypes with increase in reticulin and collagen fibers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Albrecht M (1972) Ergebnisse von Langzeitbeobachtungen bei Patienten mit chronisch myeloischer Leukämie. In: Gross R, Van de Loo J (eds) Leukämie. Springer, Berlin Heidelberg New York, pp 399–404

    Google Scholar 

  2. Anger B, Schmeiser T, Heimpel H, Robertson J, Sokal JE, Ganser A, Carbonell F (1990) Evaluation von 196 Patienten mit chronischer myeloischer Leukämie anhand eines Standard-Prognose-Modells. Onkologie 13: 109–114

    Google Scholar 

  3. Bauermeister DE (1971) Quantitation of bone marrow reticulin: a normal range. Am J Clin Pathol 56: 24–31

    Google Scholar 

  4. Buhr T, Choritz H, Georgii A (1992) The impact of megakaryocyte proliferation for the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukemia. Virchows Arch [A] 420: 473–478

    Google Scholar 

  5. Burkhardt R, Bartl R, Jäger K, Frisch B, Kettner G, Mahl G, Sund M (1986) Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings. J Clin Pathol 39: 237–252

    Google Scholar 

  6. Burkhardt R, Jaeger K, Kettner G, Helmer G (1990) Chronic myeloproliferative disorders: prognostic importance of new working classification. J Clin Pathol 43: 357–364

    Google Scholar 

  7. Cervantes F, Rozman C (1982) A multivariate analysis of prognostic factors in chronic myeloid leukemia. Blood 60: 1298–1304

    Google Scholar 

  8. Clough V, Geary CG, Hashmi K, Davson G, Knowlsen T (1979) Myelofibrosis in chronic granulocytic leukaemia. Br J Haematol 42: 515–526

    Google Scholar 

  9. Cordell JL, Falini B, Erber WN, Ghosh A, Abdulaziz Z, Mac-Donald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alka-line phosphatase (APAAP complexes). J Histochem Cytochem 32: 219–229

    Google Scholar 

  10. Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc B 34: 187–220

    Google Scholar 

  11. Dekmezian R, Kantarjian HM, Keating M, Talpaz M, McCredie KB, Freireich EJ (1987) The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemia. Cancer 59: 1739–1743

    Google Scholar 

  12. Ederer F, Axtell LM, Cutler SJ (1961) The relative survival rate: a statistical methodology. NCI Monograph 6: 101–121

    Google Scholar 

  13. Falini B, Flenghi L, Pileri SA, Gambacorta M, Bigerna B, Dürkop H, Eitelbach F, Thiele J, Cavaliere A, Martelli MF, Cardarelli N, Sabattini E, Stein H (1993) PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restriced form of the CD68 molecule. Am J Pathol (in press)

  14. Fohlmeister I, Klein H, Thiele J, Wienhold S, Fisher R (1988) Morphometric assessment of bone marrow fiber content in acute non-lymphatic leukemia at presentation. Anal Quant Cytol Histol 10: 110–114

    Google Scholar 

  15. Gatter KC, Cordell JL, Turley H, Heryet A, Kieffer N, Anstee DJ, Mason DY (1988) The immunohistomorphological detection of platelets, megakaryocytes and thrombi in routinely processed specimens. Histopathology 13: 257–267

    Google Scholar 

  16. Georgii A, Vykoupil KF, Thiele J (1980) Chronic megakaryocytic granulocytic myelosis (CMGM). A subtype of chronic myeloid leukemia. Virchows Archiv [A] 389: 253–268

    Google Scholar 

  17. Georgii A, Vykoupil KF, Thiele J (1984) Histopathology of bone marrow and clinical findings in chronic myeloproliferative disorders. In: Lennert K, Huebner K (eds) Pathology of the bone marrow. Fischer, Stuttgart, pp 147–169

    Google Scholar 

  18. Georgii A, Vykoupil KF, Buhr T, Choritz H, Döhler U, Kaloutsi V, Werner M (1990) Chronic myeloproliferative disorders in bone marrow biopsies. Pathol Res Pract 186: 3–27

    Google Scholar 

  19. Gralnick HR, Harbor J, Vogel C (1971) Myelofibrosis in chronic granulocytic leukemia. Blood 37: 152–162

    Google Scholar 

  20. Hakama M, Hakulinen T (1977) Estimating the expectation of life in cancer survival studies with incomplete follow-up information. J Chron Dis 30: 585–597

    Google Scholar 

  21. Hakulinen T (1982) Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 32: 933–942

    Google Scholar 

  22. Hakulinen T, Tenkanen L, Abeywickrama KH, Päivärinta L (1987) Testing equality of relative survival patterns based on aggregated data. Biometrics 43: 313–325

    Google Scholar 

  23. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29–36

    Google Scholar 

  24. Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology 148: 839–843

    Google Scholar 

  25. Hehlmann R, Heimpel H, Heinze B, Georgii A, Kolb HJ, et al. (1991) Multizentrische prospektive kontrollierte Studie zur Therapie der chronisch myeloischen Leukämie. Vergleich von Busulfan, Hydroxyurea und Interferon (Stand April 1990). Onkologie 14: 66–73

    Google Scholar 

  26. Hehlmann R, Heimpel H, Grieshammer M, Kolb HJ, Heinze B, et al. (1992) Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. Leukemia 6: 110–114

    Google Scholar 

  27. Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, et al. (1993) Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. Blood (in press)

  28. Kalbfleisch JD, Prentice RL (1980) The statistical analysis of failure time data. Wiley, New York

    Google Scholar 

  29. Kantarjian HM, Smith TL, McCredie KB, Keating MJ, Walters RS, Talpaz M, Hester JP, Bligham G, Gehan E, Freireich EJ (1985) Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival. Blood 66: 1326–1335

    Google Scholar 

  30. Kantarjian HM, Talpaz M, Gutterman JU (1988) Chronic myelogenous leukemia —past, present, and future. Hematol Pathol 2: 91–120

    Google Scholar 

  31. Kantarjian HM, Keating MJ, Smith TL, Talpaz M, McCredie KB (1990) Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia. Am J Med 88: 1–8

    Google Scholar 

  32. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481

    Google Scholar 

  33. Kelsey PR, Geary CG (1988) Sea-blue histiocytes and Gaucher cells in bone marrow of patients with chronic myeloid leukemia. J Clin Pathol 41: 960–962

    Google Scholar 

  34. Keyserlingk D von, Boll I, Albrecht M (1972) Elektronenmi-kroskopie und Cytochemie der “Gaucher-Zellen” bei chronischer Myelose. Klin Wochenschr 50: 510–516

    Google Scholar 

  35. Knox WF, Bhavnani M, Davson J, Geary CG (1984) Histological classification of chronic granulocytic leukaemia. Clin Lab Haematol 6: 171–175

    Google Scholar 

  36. Lazzarino M, Morra E, Castello A, Inverardi D, Coci A, Pagnucco G, Magrini U, Zei G, Bernasconi C (1986) Myelofibrosis in chronic granulocytic leukaemia: clinico-pathologic correlations and prognostic significance. Br J Haematol 64: 227–240

    Google Scholar 

  37. Levis A, Marmonnt F, Ciocca Vasino MA, Jayme A, Infelise V, Cametti G, Canta M, Resegotti L (1986) Peripheral erythroid precursors and prognosis in chronic granulocytic leukemia. Cancer 58: 229–233

    Google Scholar 

  38. Martyre MC (1991) Platelet PDGF and TGF-β: levels in myelo-proliferative disorders. Leuk Lymph 6: 1–6

    Google Scholar 

  39. Peto R, Peto J (1972) Asymptotically efficient rank invariant test procedures. J R Stat Soc A 135: 185–207

    Google Scholar 

  40. Peto R, Pike MC, Artmitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35: 1–39

    Google Scholar 

  41. Pulford KAF, Rigney EM, Micklem KJ, Jones M, Stross WP, Gatter KC, Mason DY (1989) KPl: a new monoclonal antibody that detects a monocyte/macrophage-associated antigen in routinely processed tissue sections. J Clin Pathol 42: 414–421

    Google Scholar 

  42. Radzun HJ, Hansmann ML, Heidebrecht HJ, Bödewadt-Radzun S, Wacker HH, Kreipe H, Lumbeck H, Hernandez C, Kuhn C, Parwaresch MR (1991) Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissue by monoclonal antibody Ki-M1P. Lab Invest 65: 306–315

    Google Scholar 

  43. Rozman C, Cervantes F, Feliu E (1989) Is the histological classification of chronic granulocytic leukaemia justified from the clinical point of view? Eur J Haematol 42: 150–154

    Google Scholar 

  44. Schaefer HE (1984) How to fix, decalcify and stain paraffin-embedded bone marrow biopsies. In: Lennert K, Huebner K (eds) Pathology of the bone marrow. Fischer, Stuttgart, pp 6–9

    Google Scholar 

  45. Segel GB, Simon W, Lichtman MA (1986) Variables influencing the timing of marrow transplantation in patients with chronic myelogenous leukemia. Blood 68: 1055–1064

    Google Scholar 

  46. Singal R, Belliveau RR (1988) Quantitation of megakaryocytes in normal bone marrow. Anal Quant Cytol Histol 10: 33–36

    Google Scholar 

  47. Sokal JE (1987) Prognosis in CML. Baillieres Clin Haematol 1: 907–929

    Google Scholar 

  48. Sokal JE, Cox EB, Baccarani M, Tura S, Gomez GA, Robertson JE, Tso CY, Braun TJ, Clarkson BD, Cervantes F, Rozman C, and the Italian Cooperative CML Study Group (1984) Prognostic discrimination in “good-risk” chronic granulocytic leukemia. Blood 63: 789–799

    Google Scholar 

  49. Sokal JE, Baccarani M, Tura S, Fiacchini M, Cervantes F, Rozman C, Gomez GA, Galton DAG, Canellos GP, Braun TJ, Clarkson BD, Carbonell F, Heimpel H, Extra JM, Fiere D, Nissen NI, Robertson JE, Cox EB (1985) Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation. Blood 66: 1352–1357

    Google Scholar 

  50. Sokal JE, Baccarani M, Russo D, Tura S (1988) Staging and prognosis in chronic myelogenous leukemia. Semin Hematol 25: 49–61

    Google Scholar 

  51. Stein H, Gatter KC, Asbahr H, Mason DY (1985) Methods in laboratory investigations. Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. Lab Invest 52: 676–683

    Google Scholar 

  52. Terui T, Niitsu Y, Mahara K, Fujisaki Y, Urushizaki Y, Mogi Y, Kohgo Y, Watanabe N, Ogura M, Saito H (1990) The production of transforming growth factor-β in acute megakaryo-blastic leukemia and its possible implications in myelofibrosis. Blood 75: 1540–1548

    Google Scholar 

  53. The Italian Cooperative Study Group on Chronic Myeloid Leukaemia (1988) Prospective confirmation of a prognostic classification for Ph+ chronic myeloid leukaemia. Br J Haematol 69: 463–466

    Google Scholar 

  54. The Italian Cooperative Study Group on Chronic Myeloid Leukemia (1991) Confirmation and improvement of Sokal's prognostic classification of Ph+ chronic myeloid leukemia: the value of early evaluation of the course of the disease. Ann Hematol 63: 307–314

    Google Scholar 

  55. Thiele J, Fischer R (1991) Megakaryocytopoiesis in haematological disorders: diagnostic features of bone marrow biopsies. Virchows Archiv [A] 418: 87–97

    Google Scholar 

  56. Thiele J, Fohlmeister J, Vonneguth I, Zankovich R, Fischer R (1986) The prognostic implication of clinical and histological features in Ph+ chronic myelocytic leukaemia (CML). Anticancer Res 6: 1401–1410

    Google Scholar 

  57. Thiele J, Wienhold ST, Zankovich R, Fischer R (1990) A histomorphometrical analysis of trephine biopsies of bone marrow from 65 patients with chronic myeloid leukemia —classification of patients into subgroups with different survival patterns. Anal Quant Cytol Histol 12: 103–116

    Google Scholar 

  58. Thiele J, Wagner S, Dienemann D, Wienhold S, Fischer S, Stein H (1990) An immunohistomorphological study on megakaryocyte precursor cells in bone marrow tissue from patients with chronic myeloid leukaemia (CML). Eur J Haematol 44: 63–70

    Google Scholar 

  59. Thiele J, Kvasnicka HM, Zankovich R, Fischer R, Diehl V (1991) Parameters of predictive value in chronic myeloid leukemia —the prognostic impact of histopathological variables in a multivariate regression analysis. Leuk Lymph 4: 63–74

    Google Scholar 

  60. Thiele J, Braeckel C, Wagner S, Falini B, Dienemann D, Stein H, Fischer R (1992) Macrophages in normal human bone marrow and in chronic myeloproliferative disorders: an immunohistochemical and morphometric study by a new monoclonal antibody (PG-M1) on trephine biopsies. Virchows Archiv [A] 421: 33–39

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pathology, University of Cologne, Joseph-Stelzmann-Strasse 9, D-50931, Köln, Germany

    J. Thiele, H. M. Kvasnicka, B. R. Titius, U. Parpert, R. Nebel & R. Fischer

  2. First Clinic of Medicine, University of Cologne, Germany

    R. Zankovich & V. Diehl

  3. Institute of Pathology, Free University Berlin, Germany

    D. Dienemann & H. Stein

Authors
  1. J. Thiele
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. M. Kvasnicka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. R. Titius
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. Parpert
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Nebel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Zankovich
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Dienemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. V. Diehl
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. R. Fischer
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by a grant from theDeutsche Forschungsgemeinschaft (DFG — Th 390/1-3)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thiele, J., Kvasnicka, H.M., Titius, B.R. et al. Histological features of prognostic significance in CML — an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow. Ann Hematol 66, 291–302 (1993). https://doi.org/10.1007/BF01695971

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01695971

Key words

Search

Navigation